Changes in TNF- α, IL-33, and MIP-1α before and after artificial liver support treatment and their prognostic value
CONCLUSION: ALST can significantly reduce TNF-α, IL-33, and MIP-1α levels in patients with ACLF, and postoperative TNF-α, IL-33, and MIP-1α levels have a high predictive value for patients' prognosis.PMID:38586093 | PMC:PMC10994792 | DOI:10.62347/CBKR4894 (Source: American Journal of Translational Research)
Source: American Journal of Translational Research - April 8, 2024 Category: Research Authors: Jian Zhou Zhengmao Yang Xiaoqing Yang Zhaoxun Wang Source Type: research
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG
CONCLUSIONComplement C4-derived Man5GlcNAc2 glycopeptide could be a biomarker for accurate diagnosis and therapeutic monitoring of patients with PMM2-CDG and other CDGs.FUNDINGU54NS115198 (Frontiers in Congenital Disorders of Glycosylation: NINDS; NCATS; Eunice Kennedy Shriver NICHD; Rare Disorders Consortium Disease Network); K08NS118119 (NINDS); Minnesota Partnership for Biotechnology and Medical Genomics; Rocket Fund; R01DK099551 (NIDDK); Mayo Clinic DERIVE Office; Mayo Clinic Center for Biomedical Discovery; IA/CRC/20/1/600002 (Center for Rare Disease Diagnosis, Research and Training; DBT/Wellcome Trust India Alliance)...
Source: Genomics Proteomics ... - April 8, 2024 Category: Genetics & Stem Cells Authors: Kishore Garapati Rohit Budhraja Mayank Saraswat Jinyong Kim Neha Joshi Gunveen S Sachdeva Anu Jain Anna N Ligezka Silvia Radenkovic Madan Gopal Ramarajan Savita Udainiya Kimiyo Raymond Miao He Christina Lam Austin Larson Andrew C Edmondson Kyriakie Sarafo Source Type: research
Changes in TNF- α, IL-33, and MIP-1α before and after artificial liver support treatment and their prognostic value
CONCLUSION: ALST can significantly reduce TNF-α, IL-33, and MIP-1α levels in patients with ACLF, and postoperative TNF-α, IL-33, and MIP-1α levels have a high predictive value for patients' prognosis.PMID:38586093 | PMC:PMC10994792 | DOI:10.62347/CBKR4894 (Source: American Journal of Translational Research)
Source: American Journal of Translational Research - April 8, 2024 Category: Research Authors: Jian Zhou Zhengmao Yang Xiaoqing Yang Zhaoxun Wang Source Type: research
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG
CONCLUSIONComplement C4-derived Man5GlcNAc2 glycopeptide could be a biomarker for accurate diagnosis and therapeutic monitoring of patients with PMM2-CDG and other CDGs.FUNDINGU54NS115198 (Frontiers in Congenital Disorders of Glycosylation: NINDS; NCATS; Eunice Kennedy Shriver NICHD; Rare Disorders Consortium Disease Network); K08NS118119 (NINDS); Minnesota Partnership for Biotechnology and Medical Genomics; Rocket Fund; R01DK099551 (NIDDK); Mayo Clinic DERIVE Office; Mayo Clinic Center for Biomedical Discovery; IA/CRC/20/1/600002 (Center for Rare Disease Diagnosis, Research and Training; DBT/Wellcome Trust India Alliance)...
Source: Genomics Proteomics ... - April 8, 2024 Category: Genetics & Stem Cells Authors: Kishore Garapati Rohit Budhraja Mayank Saraswat Jinyong Kim Neha Joshi Gunveen S Sachdeva Anu Jain Anna N Ligezka Silvia Radenkovic Madan Gopal Ramarajan Savita Udainiya Kimiyo Raymond Miao He Christina Lam Austin Larson Andrew C Edmondson Kyriakie Sarafo Source Type: research
Changes in TNF- α, IL-33, and MIP-1α before and after artificial liver support treatment and their prognostic value
CONCLUSION: ALST can significantly reduce TNF-α, IL-33, and MIP-1α levels in patients with ACLF, and postoperative TNF-α, IL-33, and MIP-1α levels have a high predictive value for patients' prognosis.PMID:38586093 | PMC:PMC10994792 | DOI:10.62347/CBKR4894 (Source: American Journal of Translational Research)
Source: American Journal of Translational Research - April 8, 2024 Category: Research Authors: Jian Zhou Zhengmao Yang Xiaoqing Yang Zhaoxun Wang Source Type: research
